Global Upstream Bioprocessing Market Size study, by Product, by Usage Mode, by Mode, by Application, by End-user and Regional Forecasts 2022-2032

Description

Global Upstream Bioprocessing Market is valued at approximately USD 9.54 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 9.72% over the forecast period 2024-2032. Upstream bioprocessing involves the initial stages of biomanufacturing, focusing on the cultivation and growth of microorganisms or cell cultures. This process includes media preparation, cell culture, and fermentation, where cells are grown in controlled environments to produce biological products such as proteins, vaccines, or antibodies. The primary goal is to create optimal conditions for cell growth and productivity. Upstream bioprocessing is critical for the overall success of biomanufacturing, as it directly impacts the quality and yield of the final product.

The Global Upstream Bioprocessing Market is driven by increasing demand for biopharmaceuticals driven by the high prevalence of chronic diseases. Additionally, the market is bolstered by the increasing adoption of single-use bioprocessing systems and the rising implementation of Process Analytical Technology (PAT), which enhance efficiency and reduce contamination risks. Moreover, continuous advancements in bioprocessing technologies and strategic collaborations aimed at increasing awareness and education related to bioprocessing are expected to drive the market forward. However, the high capital costs associated with upstream bioprocessing systems pose a challenge to market growth.

The key regions considered for the Global Upstream Bioprocessing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America is estimated to dominate the upstream bioprocessing market during the forecast period. The region's leadership is supported by advanced technological infrastructure and significant investments in research and development. Furthermore, the market in Asia Pacific is expected to grow at the fastest rate over the forecast period, fueled by increasing demand for biopharmaceuticals and growing investments in the biotechnology sector.

Major market players included in this report are:

Corning, Inc.
Danaher Corporation (Cytvia)
Eppendorf AG
Merck KGaA
PBS Biotech, Inc.
Sartorius AG
Thermo Fisher Scientific Inc.
Applikon Biotechnology
Boehringer Ingelheim GmbH
CellGenix GmbH

The detailed segments and sub-segment of the market are explained below:

By Product

Bioreactors/Fermenters
Cell culture products
Filters
Bioreactor accessories
Bags & containers
Other products

By Usage Mode

Multi-use
Single-use

By Mode

In-house
Outsourced

By Application

Monoclonal antibody production
Vaccine production
Cell and gene therapy production
Other applications

By End-user

Biopharmaceutical companies
CDMOs and CROs
Research and academic institutes

By Region:

North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:

Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

Chapter 1. Global Upstream Bioprocessing Market Executive Summary

1.1. Global Upstream Bioprocessing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Usage Mode
- 1.3.3. By Mode
- 1.3.4. By Application
- 1.3.5. By End-user
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Upstream Bioprocessing Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Upstream Bioprocessing Market Dynamics

3.1. Market Drivers
- 3.1.1. Increasing Adoption of Single-use Bioprocessing Systems
- 3.1.2. Rising Implementation of Process Analytical Technology (PAT)
- 3.1.3. Increasing Demand for Biopharmaceuticals
3.2. Market Challenges
- 3.2.1. Technical and Operational Challenges Related to Upstream Bioprocessing
- 3.2.2. High Capital Costs
3.3. Market Opportunities
- 3.3.1. Growing Investment in R&D
- 3.3.2. Development of Innovative Solutions
- 3.3.3. Collaboration and Partnerships for Increasing Awareness and Education

Chapter 4. Global Upstream Bioprocessing Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model
- 4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Upstream Bioprocessing Market Size & Forecasts by Product 2022-2032

5.1. Segment Dashboard
5.2. Global Upstream Bioprocessing Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 5.2.1. Bioreactors/Fermenters
- 5.2.2. Cell culture products
- 5.2.3. Filters
- 5.2.4. Bioreactor accessories
- 5.2.5. Bags & containers
- 5.2.6. Other products

Chapter 6. Global Upstream Bioprocessing Market Size & Forecasts by Usage Mode 2022-2032

6.1. Segment Dashboard
6.2. Global Upstream Bioprocessing Market: Usage Mode Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 6.2.1. Multi-use
- 6.2.2. Single-use

Chapter 7. Global Upstream Bioprocessing Market Size & Forecasts by Mode 2022-2032

7.1. Segment Dashboard
7.2. Global Upstream Bioprocessing Market: Mode Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 7.2.1. In-house
- 7.2.2. Outsourced

Chapter 8. Global Upstream Bioprocessing Market Size & Forecasts by Application 2022-2032

8.1. Segment Dashboard
8.2. Global Upstream Bioprocessing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 8.2.1. Monoclonal antibody production
- 8.2.2. Vaccine production
- 8.2.3. Cell and gene therapy production
- 8.2.4. Other applications

Chapter 9. Global Upstream Bioprocessing Market Size & Forecasts by End-user 2022-2032

9.1. Segment Dashboard
9.2. Global Upstream Bioprocessing Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
- 9.2.1. Biopharmaceutical companies
- 9.2.2. CDMOs and CROs
- 9.2.3. Research and academic institutes

Chapter 10. Global Upstream Bioprocessing Market Size & Forecasts by Region 2022-2032

10.1. North America Upstream Bioprocessing Market
- 10.1.1. U.S. Upstream Bioprocessing Market
  - 10.1.1.1. Product breakdown size & forecasts, 2022-2032
  - 10.1.1.2. Usage Mode breakdown size & forecasts, 2022-2032
  - 10.1.1.3. Mode breakdown size & forecasts, 2022-2032
  - 10.1.1.4. Application breakdown size & forecasts, 2022-2032
  - 10.1.1.5. End-user breakdown size & forecasts, 2022-2032
- 10.1.2. Canada Upstream Bioprocessing Market
  - 10.1.2.1. Product breakdown size & forecasts, 2022-2032
  - 10.1.2.2. Usage Mode breakdown size & forecasts, 2022-2032
  - 10.1.2.3. Mode breakdown size & forecasts, 2022-2032
  - 10.1.2.4. Application breakdown size & forecasts, 2022-2032
  - 10.1.2.5. End-user breakdown size & forecasts, 2022-2032
10.2. Europe Upstream Bioprocessing Market
- 10.2.1. U.K. Upstream Bioprocessing Market
- 10.2.2. Germany Upstream Bioprocessing Market
- 10.2.3. France Upstream Bioprocessing Market
- 10.2.4. Spain Upstream Bioprocessing Market
- 10.2.5. Italy Upstream Bioprocessing Market
- 10.2.6. Rest of Europe Upstream Bioprocessing Market
10.3. Asia-Pacific Upstream Bioprocessing Market
- 10.3.1. China Upstream Bioprocessing Market
- 10.3.2. India Upstream Bioprocessing Market
- 10.3.3. Japan Upstream Bioprocessing Market
- 10.3.4. Australia Upstream Bioprocessing Market
- 10.3.5. South Korea Upstream Bioprocessing Market
- 10.3.6. Rest of Asia Pacific Upstream Bioprocessing Market
10.4. Latin America Upstream Bioprocessing Market
- 10.4.1. Brazil Upstream Bioprocessing Market
- 10.4.2. Mexico Upstream Bioprocessing Market
- 10.4.3. Rest of Latin America Upstream Bioprocessing Market
10.5. Middle East & Africa Upstream Bioprocessing Market
- 10.5.1. Saudi Arabia Upstream Bioprocessing Market
- 10.5.2. South Africa Upstream Bioprocessing Market
- 10.5.3. Rest of Middle East & Africa Upstream Bioprocessing Market

Chapter 11. Competitive Intelligence

11.1. Key Company SWOT Analysis
11.2. Top Market Strategies
11.3. Company Profiles
- 11.3.1. Corning, Inc.
  - 11.3.1.1. Key Information
  - 11.3.1.2. Overview
  - 11.3.1.3. Financial (Subject to Data Availability)
  - 11.3.1.4. Product Summary
  - 11.3.1.5. Market Strategies
- 11.3.2. Danaher Corporation (Cytvia)
- 11.3.3. Eppendorf AG
- 11.3.4. Merck KGaA
- 11.3.5. PBS Biotech, Inc.
- 11.3.6. Sartorius AG
- 11.3.7. Thermo Fisher Scientific Inc.
- 11.3.8. Applikon Biotechnology
- 11.3.9. Boehringer Ingelheim GmbH
- 11.3.10. CellGenix GmbH

Chapter 12. Research Process

12.1. Research Process
- 12.1.1. Data Mining
- 12.1.2. Analysis
- 12.1.3. Market Estimation
- 12.1.4. Validation
- 12.1.5. Publishing
12.2. Research Attributes